Replies to post #252723 on Biotech Values

[DewDiligence]

MYNZ’s ColoAlert clinical data look compelling, but (as you know) the test is not yet approved in the US.

Moreover, for quality-control reasons I prefer the downstream processing method employed by EXAS’ Cologuard, as noted in #msg-173055394.